Aravive ARAV
$ 0.04
-13.39%
Quarterly report 2023-Q3
added 11-09-2023
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Rekha Hemrajani |
Employees in the company |
16 |
Shares |
36.4 M |
Market Cap[1] |
$ 1.45 M |
EBITDA (LTM) |
$ -67.3 M |
P/E (LTM) |
-0.2 |
P/S (LTM) |
0.45 |
EPS (LTM) |
-0.65 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.